Navigation Links
An end to fear
Date:3/11/2009

A team of Dutch researchers under the leadership of Vici-winner Merel Kindt has successfully reduced the fear response. They weakened fear memories in human volunteers by administering the beta-blocker propranolol. Interestingly, the fear response does not return over the course of time. Top journal Nature Neuroscience published the findings on 15 February 2009.

Until recently, it was assumed that the fear memory could not be deleted. However, Klindt's team has demonstrated that changes can indeed be effected in the emotional memory of human beings.

Storing changes

Before fear memories are stored in the long-term memory, there is a temporary labile phase. During this phase, protein synthesis takes place that 'records' the memories. The traditional idea was that the memory is established after this phase and can, therefore, no longer be altered. However, this protein synthesis also occurs when memories are retrieved from the memory and so there is once again a labile phase at that moment. The researchers managed to successfully intervene in this phase.

During their experiments the researchers showed images of two different spiders to the human volunteers. One of the spider images was accompanied by a pain stimulus and the other was not. Eventually the human volunteers exhibited a startle response (fear) upon seeing the first spider without the pain stimulus being administered. The anxiety for this spider had therefore been acquired.

One day later the fear memory was reactivated, as a result of which the protein synthesis occurred again. Just before the reactivation, the human volunteers were administered the beta-blocker propranolol. On the third day it was found that the volunteers who had been administered propranolol no longer exhibited a fear response on seeing the spider, unlike the control group who had been administered a placebo. The group that had received propranolol but whose memory was not reactivated still exhibited a strong startle response. The fear response was measured using two electrodes under the eye that measured the eye-blinking reflex. The response measured is one directly initiated by the amygdala, the emotional centre of the brain.

Searching in deleted items

Cognitive behavioural therapy is currently the prevailing and most effective method for treating anxiety disorders. During such a treatment the patient is exposed to the fear-eliciting stimulus without the feared consequence occurring. This method frequently only achieves short-term results and the fears often return over the course of time.

Interestingly, after the treatment with propranolol and memory reactivation, fear memories can no longer be recalled by means of a much-used method in which the individual pain stimuli are readministered. This indicates that the anxiety memory is either completely erased or could no longer be found in the memory. It should be noted, however, that the human volunteers could remember the association between the spider and the pain stimulus but that this no longer elicited any emotional response. In the next phase of the research, Kindt and her colleagues shall investigate the long-term effects of administering propranolol.

Treatment of anxiety disorders

The researchers expect that the results from this study can contribute to a new procedure for the treatment of patients with anxiety disorders. The method intervenes in the memory in a completely different way to conventional treatments. Whereas the traditional cognitive behavioural therapies frequently focus on the creation of new memories, this method focuses on the weakening of the existing emotional memory.

In 2007, Merel Kindt received a Vici grant from NWO for her innovative research. This study was carried out by Merel Kindt, Marieke Soeter and Bram Vervliet at the Universiteit van Amsterdam.


'/>"/>

Contact: Merel Kindt
M.Kindt@uva.nl
31-205-256-044-31205
Netherlands Organization for Scientific Research
Source:Eurekalert

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
Breaking Biology News(10 mins):
(Date:5/18/2016)... ... May 18, 2016 , ... Tech Coast Angels ... Award to Cognition Therapeutics at the annual ACA Summit last week in Philadelphia. ... by one of ACA’s member angel groups. It is the highest honor available for ...
(Date:5/18/2016)... ... May 18, 2016 , ... STACS DNA Inc., the sample tracking software company, ... sexual assault kit processing to help them save time and reduce errors. , Sexual ... to be processed and victims informed of results. Due to a previous lack of ...
(Date:5/18/2016)... (PRWEB) , ... May 18, 2016 , ... Ryan Benton ... a life expectancy in the late teens to early twenties. DMD is a relatively ... 2009, at the age of 22, Benton’s condition was critical. He met with the ...
(Date:5/17/2016)... , ... May 17, 2016 , ... ... and BioSmartSA, a healthcare consultancy based in Saudi Arabia, have formed a partnership ... to healthcare providers in the Kingdom of Saudi Arabia (KSA). , The ...
Breaking Biology Technology: